Home/Filings/4/0001104659-25-095035
4//SEC Filing

Jeremy M. Sclar 2012 Irrevocable Family Trust 4

Accession 0001104659-25-095035

CIK 0001374339other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:17 PM ET

Size

18.3 KB

Accession

0001104659-25-095035

Insider Transaction Report

Form 4
Period: 2025-07-25
Transactions
  • Purchase

    Warrant to Purchase Common Shares

    2025-07-29+3,139,5333,139,533 total
    Common Shares (3,139,533 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6743,012,785 total
  • Exercise of In-Money

    Tranche A Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6742,315,111 total
  • Exercise of In-Money

    Tranche B Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Tranche C Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6743,710,459 total
Footnotes (4)
  • [F1]On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F2]On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F3]On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F4]On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.

Issuer

ProMIS Neurosciences Inc.

CIK 0001374339

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0002089163

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:17 PM ET
Size
18.3 KB